Evaluation/Desired Outcomes

Improvement in hematologic parameters in patients with B-cell chronic lymphocytic leukemia

alemtuzumab is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.